CytoMed Therapeutics Limited Comprehensive Income Attributable To Owners Of Parent
CytoMed Therapeutics Limited (GDTC) reported Comprehensive Income Attributable To Owners Of Parent of -SGD 3.85 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Income Statement › Unrealized Gains
ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent · last filed 2026-03-31
SGD
| Period end | Comprehensive Income Attributable To Owners Of Parent 12 month |
|---|---|
| 2025-12-31 | -3.85M SGD 20-F · filed 2026-03-31 |
| 2024-12-31 | -2.35M SGD 20-F · filed 2026-03-31 |
| 2023-12-31 | -4.22M SGD 20-F · filed 2026-03-31 |
| 2022-12-31 | -3.23M SGD 20-F · filed 2025-04-28 |
| 2021-12-31 | -2.07M SGD 20-F · filed 2024-04-22 |
| 2020-12-31 | -1.94M SGD 20-F · filed 2023-05-01 |
USD
| Period end | Comprehensive Income Attributable To Owners Of Parent 12 month |
|---|---|
| 2025-12-31 | -$2.99M 20-F · filed 2026-03-31 |
| 2024-12-31 | -$1.72M 20-F · filed 2025-04-28 |
| 2023-12-31 | -$3.20M 20-F · filed 2024-04-22 |
| 2022-12-31 | -$2.41M 20-F · filed 2023-05-01 |